Published: 16 June 2020
Author(s): Jean M. Connors
Issue: August 2020
Section: Commentary

The increased risk of thrombosis associated with cancer has been known since Trousseau's observations in the 19th century. Roughly 15 to 20 years ago, studies found that patients with cancer and thrombosis had a higher likelihood of recurrent thrombosis despite the use of anticoagulation, and an increased risk of bleeding with anticoagulation, than patients without cancer [1]. At that time, cancer treatments were limited to combinations of surgery and radiation, and conventional chemotherapy with regimens comprised of chemical agents that impaired cell replication in an indiscriminate manner.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.